Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


20.06.2022

2 Am J Hematol
2 Blood
1 BMC Cancer
1 Bone Marrow Transplant
1 Br J Haematol
1 Eur J Haematol
1 Int J Cancer
1 J Natl Cancer Inst
4 Leuk Lymphoma
2 Leukemia
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. DU J, Wei R, Jiang S, Jiang H, et al
    CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status.
    Am J Hematol. 2022;97:933-941.
    PubMed         Abstract available

  2. ABUSHUKAIR H, Syaj S, Ababneh O, Qarqash A, et al
    First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenstrom's Macroglobulinemia: A systematic review and meta-analysis.
    Am J Hematol. 2022;97:942-950.
    PubMed         Abstract available


    Blood

  3. KAMBHAMPATI S, Saumoy M, Schneider Y, Pak S, et al
    Cost Effectiveness of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-cell Lymphoma.
    Blood. 2022 Jun 14. pii: 485545. doi: 10.1182/blood.2022016624.
    PubMed         Abstract available

  4. QI Y, Zhao M, Hu Y, Wang Y, et al
    Efficacy and safety of CD19-specific CAR T-cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL.
    Blood. 2022 Mar 25. pii: 484499. doi: 10.1182/blood.2021013733.
    PubMed         Abstract available


    BMC Cancer

  5. YAGI Y, Kanemasa Y, Sasaki Y, Ohigashi A, et al
    Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study.
    BMC Cancer. 2022;22:640.
    PubMed         Abstract available


    Bone Marrow Transplant

  6. MEISSNER J, Schmitt M, Andrulis M, Schweizer L, et al
    Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2022 Jun 9. pii: 10.1038/s41409-022-01734.
    PubMed        


    Br J Haematol

  7. KAJI FA, Martinez-Calle N, Sovani V, Fox CP, et al
    Rare central nervous system lymphomas.
    Br J Haematol. 2022;197:662-678.
    PubMed         Abstract available


    Eur J Haematol

  8. ABBASOV E, Metzner B, Muller TH, Casper J, et al
    Herpes Zoster prophylaxis with low-dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation (ASCT).
    Eur J Haematol. 2022 Jun 10. doi: 10.1111/ejh.13810.
    PubMed         Abstract available


    Int J Cancer

  9. MAFRA A, Laversanne M, Gospodarowicz M, Klinger P, et al
    Global patterns of non-Hodgkin lymphoma in 2020.
    Int J Cancer. 2022 Jun 13. doi: 10.1002/ijc.34163.
    PubMed         Abstract available


    J Natl Cancer Inst

  10. CASTILHO JL, Bian A, Jenkins CA, Shepherd BE, et al
    CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    J Natl Cancer Inst. 2022;114:854-862.
    PubMed         Abstract available


    Leuk Lymphoma

  11. QUALLS D, Kumar A, Epstein-Peterson ZD
    Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies.
    Leuk Lymphoma. 2022 Jun 15:1-13. doi: 10.1080/10428194.2022.2086244.
    PubMed         Abstract available

  12. ERIKSEN PRG, Clasen-Linde E, Brown PN, Haunstrup L, et al
    NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980-2017: a nationwide cohort study.
    Leuk Lymphoma. 2022 Jun 14:1-10. doi: 10.1080/10428194.2022.2087069.
    PubMed         Abstract available

  13. LEVY M, Dupuis J, Charpy C, Martin A, et al
    Rituximab or rituximab plus chlorambucil for translocation (11;18)-negative gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomized observational study.
    Leuk Lymphoma. 2022 Jun 10:1-7. doi: 10.1080/10428194.2022.2086248.
    PubMed         Abstract available

  14. TEO YH, Teo YN, Khoo LP, Chang EWY, et al
    Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort study.
    Leuk Lymphoma. 2022 Jun 10:1-4. doi: 10.1080/10428194.2022.2086242.
    PubMed        


    Leukemia

  15. LAUER EM, Mutter J, Scherer F
    Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.
    Leukemia. 2022 Jun 14. pii: 10.1038/s41375-022-01618.
    PubMed         Abstract available

  16. DONG G, Liu X, Wang L, Yin W, et al
    Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma.
    Leukemia. 2022 Jun 13. pii: 10.1038/s41375-022-01623.
    PubMed         Abstract available


    Oncogene

  17. HANG X, Zhao L, Wu B, Li S, et al
    BCL-2 isoform beta promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma.
    Oncogene. 2022 Jun 14. pii: 10.1038/s41388-022-02372.
    PubMed         Abstract available


    PLoS One

  18. OGISO A, Mizuno T, Ito K, Mizokami F, et al
    Use of benzodiazepines is the risk factor for infection in patients aged 80 years or older with diffuse large B-cell lymphoma: A single-institution retrospective study.
    PLoS One. 2022;17:e0269362.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: